Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells. [electronic resource]
- Oncogene Mar 2002
- 2066-78 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0950-9232
10.1038/sj.onc.1205243 doi
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--pharmacology Animals Blotting, Western Breast Neoplasms--metabolism Cell Survival--drug effects Chromones--pharmacology Cyclic AMP-Dependent Protein Kinases--metabolism Electrophoretic Mobility Shift Assay ErbB Receptors--metabolism Flavonoids--pharmacology Gene Expression Regulation, Neoplastic--drug effects I-kappa B Kinase Mice Mice, Transgenic Morpholines--pharmacology NF-kappa B--metabolism Neuregulin-1--antagonists & inhibitors Oncogene Protein p21(ras)--metabolism Phosphatidylinositol 3-Kinases--metabolism Phosphoinositide-3 Kinase Inhibitors Phosphorylation--drug effects Protein Serine-Threonine Kinases--metabolism Proto-Oncogene Proteins c-myc--genetics Receptor, ErbB-2--metabolism Signal Transduction--drug effects Transcription, Genetic--drug effects Tumor Cells, Cultured Tumor Necrosis Factor-alpha--pharmacology